The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|9|5|627-635

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.5, 2010-11, pp. : 627-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-01 ,pp. : 303-313

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders

By  

Current Pharmaceutical Design, Vol. 6, Iss. 17, 2000-11 ,pp. : 1755-1776

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 153-157

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-receptor Engineering and its Application Towards the Complementation of Genetic Disease and Target Identification

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 4, 2005-05 ,pp. : 413-420

Bentham Science Publishers

Access to resources Recommend Favorite